Family Medicine · Granbury, TX
NPI
1790780930
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1204 Medical Plaza Ct
Granbury, TX, 76048
Phone (817) 573-5688
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
2,366 services
Medicare patients, 2024
515
Average age 74
Drug cost, 2024
$1.3M
12,494 prescriptions
Company payments, 2025
$1,208
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles B Smith was code 99214 (office e&m - established), 575 times for 405 patients. In total Charles B Smith billed 2,366 services in 33 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 575 | 405 | $80.12 | $46K |
| 99213 Office E&M - Established | Office | 424 | 390 | $56.66 | $24K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 351 | 351 | $123.33 | $43K |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 83 | 83 | $17.69 | $1,468 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 34 | 33 | $40.42 | $1,374 |
| 81002 Clinical Chemistry | Office | 26 | 22 | $3.41 | $88.66 |
| 96372 Injection Administration | Office | 26 | 17 | $10.38 | $270 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 23 | 23 | $157.56 | $3,624 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 21 | 12 | $28.59 | $600 |
| 82270 Immunoassay | Office | 11 | 11 | $4.29 | $47.19 |
By year: 2022 $377K for 10,942 services; 2023 $362K for 11,163 services; 2024 $129K for 2,366 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 83 | 83 | $17.69 | $1,468 |
| 81002 Clinical Chemistry | 26 | 22 | $3.41 | $88.66 |
| 82270 Immunoassay | 11 | 11 | $4.29 | $47.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles B Smith prescribed most often to Medicare patients was Levothyroxine Sodium, with 676 prescriptions and refills. In total Charles B Smith wrote 12,494 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 676 | 1,997 | 213 | $7,208 |
| Atorvastatin Calcium Generic | 602 | 1,740 | 183 | $4,866 |
| Amlodipine Besylate Generic | 382 | 1,120 | 121 | $2,382 |
| Lisinopril Generic | 360 | 1,051 | 111 | $2,428 |
| Rosuvastatin Calcium Generic | 360 | 1,032 | 109 | $3,580 |
| Pantoprazole Sodium Generic | 287 | 781 | 91 | $3,993 |
| Alprazolam Generic | 267 | 346 | 56 | $1,538 |
| Gabapentin Generic | 255 | 608 | 82 | $4,741 |
| Losartan Potassium Generic | 246 | 712 | 76 | $2,132 |
| Metformin Hcl Generic | 237 | 688 | 85 | $2,063 |
| Tamsulosin Hcl Generic | 229 | 666 | 70 | $3,296 |
| Trazodone Hcl Generic | 209 | 501 | 56 | $1,974 |
| Ezetimibe Generic | 191 | 554 | 64 | $3,596 |
| Simvastatin Generic | 182 | 541 | 52 | $1,233 |
| Celecoxib Generic | 177 | 457 | 53 | $6,054 |
Brand drugs: 1,737 claims; generic drugs: 10,639 claims; opioid claims: 65.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles B Smith $1,208 ($1,208 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $208.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $208 |
| Abbvie Inc. ABBV | 14 | $192 |
| Exact Sciences Corporation EXAS | 7 | $143 |
| Novo Nordisk Inc NVO | 5 | $101 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $71.42 |
| Abbott Laboratories ABT | 3 | $69.29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $42.47 |
| Eisai Inc. 4523.T | 1 | $29.7 |
| Amgen Inc. AMGN | 2 | $27.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.